Instituto de Investigación Biomédica da Coruña (INIBIC): Envíos recentes
Mostrando ítems 26-30 de 803
-
Sacubitril-valsartan, clinical benefits and related mechanisms of action in heart failure with reduced ejection fraction: a review
(Frontiers, 2021-11-11)[Abstract] Heart failure (HF) is a clinical syndrome characterized by the presence of dyspnea or limited exertion due to impaired cardiac ventricular filling and/or blood ejection. Because of its high prevalence, it is a ... -
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
(Springer Nature, 2024-01-09)[Abstract] Rationale: In-stent reocclusion after endovascular therapy has a negative impact on outcomes in acute ischemic stroke (AIS) due to tandem lesions (TL). Optimal antiplatelet therapy approach in these patients ... -
Conduction system pacing and atrioventricular node ablation in heart failure: the PACE-FIB study design
(John Wiley & Sons, 2023-09-20)[Abstract] Aims: Atrial fibrillation (AF) worsens the prognosis of patients with heart failure (HF). Successful treatments are still very scarce for those with permanent AF and preserved (HFpEF) or mildly reduced ... -
SERCA2a protein levels are unaltered in human heart failure
(American Heart Association (AHA), 2023-08-14) -
Inotropic therapy in patients with advanced heart failure: a clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
(John Wiley & Sons, 2023-02-27)[Abstract] This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart ...